Skip to main content

Security report for endosane.com

Endosane Pharmaceuticals GmbH · Healthcare · Germany

Medium risk. 3 critical or high findings in Security headers and GDPR outside view.

Security score

72/100

Risk levelMedium

0–100, higher is better. How it is calculated

Endosane Pharmaceuticals GmbH is a small healthcare-focused biopharmaceutical company specializing in innovative mental health treatments targeting the endocannabinoid system. Founded in 2021 and based in Berlin, Germany, the company leverages deep neuroscience insights to address unmet needs in psychiatric disorders such as schizophrenia and PTSD. Their business model centers on research and clinical trial development, positioning them as a niche innovator in mental health therapeutics. The website reflects a professional and consistent brand presence with clear navigation and relevant content aimed at patients, healthcare professionals, investors, and caregivers. Technically, the site is built on Squarespace using common web libraries like jQuery and Popper.js, but suffers from slow performance and lacks advanced analytics or marketing tracking. Security posture is weak due to the absence of a valid SSL certificate and modern TLS protocols, exposing the site to risks and undermining user trust. Privacy compliance is basic, with a privacy policy and cookie banner present but no GDPR-specific indicators or terms of service. Contact information is provided via a physical address and a contact form with captcha protection, but no verified company emails or phone numbers are listed. Overall, the site is functional and informative but requires significant improvements in security and compliance to enhance trust and protect user data.

Scanned

NIS2 and GDPR posture

GDPR outside view
43/ 100 · High
Checks completed
7of 7

NIS2 Art. 21(2)

  1. (a) Risk analysis and security policies: Not visible from outside
  2. (b) Incident handling: One indicator
  3. (c) Business continuity, backups and crisis management: Not visible from outside
  4. (d) Supply chain security: Not visible from outside
  5. (e) Secure acquisition, development and maintenance, including vulnerability handling: Partly checked
  6. (f) Assessing the effectiveness of security measures: Not visible from outside
  7. (g) Cyber hygiene and security training: Not visible from outside
  8. (h) Cryptography and encryption: Partly checked
  9. (i) HR security, access control and asset management: One indicator
  10. (j) Multi-factor authentication and secured communications: Not visible from outside

This scan rated NIS2 with an earlier keyword method that is no longer shown; rescan for the per-article view. Risk management, continuity, supply chain, training, MFA, management oversight (Art. 20) and incident reporting (Art. 23) need internal evidence, and Guard cannot tell whether NIS2 applies to this organisation.

GDPR is indicative only, based on publicly visible signals: Articles 7, 12, 13 and 32 of Regulation (EU) 2016/679 and Article 5(3) of the ePrivacy Directive. Not a certification or legal assessment.

Priority findings

3 findings rated critical or high. Fix these first.

  1. Security headers

    Security headers are instructions your web server sends to every visitor’s browser. Missing ones leave visitors more exposed to attacks such as clickjacking and injected scripts.

    • High

      Missing Content-Security-Policy header

      Controls resources the browser is allowed to load

      What to do: Implement a Content-Security-Policy appropriate for your application

      • ASVS V3.4.3
      • OWASP Secure Headers: OWASP Secure Headers Project recommends Content-Security-Policy: default-src 'self'; form-action 'self'; base-uri 'self'; object-src 'none';…

  2. GDPR outside view

    These are the privacy signals visitors and data protection authorities look for under GDPR.

    • High

      No Cookie Policy found

      GDPR requires clear information about cookie usage

      What to do: Add a dedicated cookie policy explaining cookie usage and purposes

    • High

      No Cookie Consent Banner found

      GDPR requires explicit consent for non-essential cookies

      What to do: Implement a cookie consent banner that appears on first visit

Need hands-on remediation? Email guard@offseq.com

Keep watching endosane.com

This scan found 20 issues across 6 checks. Monitoring re-runs those checks daily, emails you when something material changes and records each fix, so you can show progress.

Daily monitoring

Recommended

€25per month

  • TLS certificates and expiry
  • DNS records
  • SPF, DKIM and DMARC
  • Security headers
  • GDPR and NIS2 posture
  • Exposed services
  • Third-party trackers
  • Security score drift

Email alerts on material changes and an exportable JSON history of every change.

Billed monthly to your card. Cancel anytime. The full timeline opens with your unlock code.

Full report

€39.90one-time

  • The complete analysis as a PDF you can cite
  • Email delivery with an unlock code
  • Lifetime access to this report

Prices incl. 21% VAT. Secure checkout by Mollie; sold by SEQ SIA, Latvia.

Results by check

Each check with its score, findings and the evidence it collected.

How this score is calculated

The security score runs 0–100, higher is better. It is the plain average of the security checks that completed in this scan, each counted equally. A check that could not run is left out: it counts neither as a pass nor as a fail.

Counted in this score

SSL/TLS
90
Security headers
45
Email security
70
DNS health
85
Network security
100
GDPR outside view
43
Average
72

Not counted

  • NIS2 outside view: Re-weights evidence from the TLS, email, DNS, network and hygiene checks, so counting it would count that evidence twice. Shown on its own.
  • OffSeq Observations: An AI reading of the site, useful context but not reproducible evidence. Shown on its own.

Findings that cap the score at 49

Each of these is serious on its own, so while any is present the site cannot rate better than high risk, however good the other checks are.

  • The certificate is not trusted by browsers
  • The website is not served over HTTPS
  • A database, remote desktop, file-sharing or Telnet service is reachable from the internet
  • The page loads a script from a compromised source
  • The domain registration has expired
  • SPF authorises every server to send mail as the domain

Partial scans

When the site blocks Guard or most checks cannot run, the score covers only the checks that ran (usually DNS and email), is capped at 75 and is shown as partial, without a risk level.

Risk levels

  • Critical0–25
  • High26–49
  • Medium50–75
  • Low76–100

Technical appendix

Business context, site observations and technical notes gathered during the scan, and the standards behind each reference.

Business context

Business profile

Endosane operates in a specialized healthcare sector focusing on mental health innovation through the endocannabinoid system. Their competitive advantage lies in deep neuroscience expertise and a clinical trial platform targeting biologically validated mechanisms in psychiatric disorders. The company targets a diverse audience including patients, healthcare providers, investors, and caregivers, indicating a multi-stakeholder engagement approach. Revenue streams likely include research partnerships, clinical trial funding, and potential future therapeutics commercialization. The website's limited marketing and analytics footprint suggests a focus on organic growth and professional outreach rather than aggressive digital marketing. Partnerships or subsidiaries are not evident, indicating a lean organizational structure. Strategic observations highlight the need for enhanced digital security and compliance to support growth and stakeholder confidence.

Security posture

The current security maturity level of the website is low. The absence of a valid SSL certificate and lack of TLS protocol support are critical vulnerabilities that expose user data to interception and undermine trust. While some security headers like HSTS, X-Content-Type-Options, and X-Frame-Options are present, they are insufficient without proper HTTPS enforcement. No incident response or vulnerability disclosure policies are found, indicating limited preparedness for security incidents. The contact form uses captcha, which is a positive control against automated abuse, but overall data protection practices and compliance with GDPR or other regulations are minimal. The business impact of these vulnerabilities includes potential data breaches, loss of user trust, and regulatory non-compliance. Recommendations include immediate SSL deployment, enabling modern TLS, and establishing clear security policies and incident response mechanisms.

Recommendations

  1. Install and maintain a valid SSL/TLS certificate to enable HTTPS and protect data in transit.
  2. Enable modern TLS protocols (TLS 1.2 or 1.3) and configure strong cipher suites for secure communications.
  3. Develop and publish comprehensive privacy, security, and terms of service policies to improve compliance and transparency.
  4. Implement a vulnerability disclosure policy and incident response plan to enhance security readiness.
  5. Enhance website performance and accessibility to improve user experience and SEO.

Contact details published on the site

Addresses
Legal name
Endosane Pharmaceuticals GmbH
Technical notes

Notes

The website is hosted on Squarespace, leveraging its CMS and hosting infrastructure. It uses common JavaScript libraries such as jQuery, Popper.js, and Tippy.js for UI enhancements. The site is mobile optimized with responsive design but suffers from slow loading times likely due to large images and lack of caching optimizations. SEO is supported by proper meta tags, Open Graph tags, and JSON-LD structured data, improving search engine visibility. However, the lack of SSL and modern security protocols represents a significant technical debt and risk. There are no advanced analytics or marketing tools detected, indicating a basic digital maturity level. Opportunities exist to modernize the tech stack, improve performance, and strengthen security configurations to support business growth and user trust.
Standards and sources

Reference chips under each finding point to the standard, regulation or specification the finding relates to. They are taken from the official datasets below and mapped conservatively: a finding with no defensible link shows none. NIS2 and GDPR references mark where a finding is relevant evidence, not a compliance verdict. Implementing Regulation (EU) 2024/2690 binds digital infrastructure and digital service providers; for other entities it is the most detailed public reading of the Article 21 measures. WCAG, EN 301 549, European Accessibility Act and Web Accessibility Directive references name the requirement an automated accessibility rule relates to; they are not a conformance verdict.

Retrieved 2026-10-25

Reviews of this site

Share your experience with endosane.com. Every review is verified by email and published after moderation.

Overall rating
Select a rating
4000 characters remaining

We’ll email you to confirm your review and keep your details private.

Community rating

No published reviews yet. Be the first to review endosane.com.

Feedback on this report

Rate this report, add an optional comment, and tell us if you want a security specialist to follow up.

Overall report quality
Select a rating
2000 characters remaining

We only use your feedback to improve Guard reports. Contact details are never shared.